Mikael Norman1, Katarina Åberg2, Karin Holmsten3, Vania Weibel4, Cecilia Ekéus2. 1. Divisions of Pediatrics, Department of Clinical Science, Intervention and Technology, Department of Neonatal Medicine, Karolinska University Hospital, Stockholm, Sweden; and mikael.norman@ki.se. 2. Reproductive Health, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden and. 3. IVF Clinic Umeå, IVF Sweden AB, Umeå, Sweden. 4. Department of Obstetrics and Gynecology.
Abstract
BACKGROUND: Before hospital discharge, newborn infants should be assessed for the risk of excessive hyperbilirubinemia. We determined maternal and obstetric risk factors for hyperbilirubinemia in infants born at term (gestational age ≥37 weeks) to form an individualized risk assessment tool for clinical use. METHODS: This was a population-based study with data from the Swedish Medical Birth Register from 1999 to 2012, including 1,261,948 singleton infants. Outcome was defined as infants diagnosed with hyperbilirubinemia (N = 23,711), excluding all cases of hemolytic (immune-mediated or other specified hemolytic) diseases of the newborn. RESULTS: Risk factors with an adjusted odds ratio (aOR) for neonatal hyperbilirubinemia of ≥1.5 (medium-sized effect or more) were gestational age 37 to 38 weeks (aOR = 2.83), failed vacuum extraction (aOR = 2.79), vacuum extraction (aOR = 2.22), Asian mother (aOR = 2.09), primipara (aOR = 2.06), large-for-gestational-age infant (aOR = 1.84), obese mother (aOR = 1.83), and small-for-gestational-age infant (aOR = 1.66). Planned cesarean delivery (CD) was associated with a reduced risk (aOR = 0.45). Without any of these risk factors (normal birth weight infant delivered vaginally at 39 to 41 weeks' gestation by a non-Asian, nonobese, multiparous mother) the rate of nonhemolytic neonatal hyperbilirubinemia was 0.7%. In relation to the combined load of different risk factors, rates of neonatal hyperbilirubinemia ranged from 0.2% to 25%. CONCLUSIONS: Collection of a few easily available maternal and obstetric risk factors predicts >100-fold variation in the incidence of neonatal hyperbilirubinemia. The information provided herein enables individualized risk prediction with interactions between different risk factors taken into account.
BACKGROUND: Before hospital discharge, newborn infants should be assessed for the risk of excessive hyperbilirubinemia. We determined maternal and obstetric risk factors for hyperbilirubinemia in infants born at term (gestational age ≥37 weeks) to form an individualized risk assessment tool for clinical use. METHODS: This was a population-based study with data from the Swedish Medical Birth Register from 1999 to 2012, including 1,261,948 singleton infants. Outcome was defined as infants diagnosed with hyperbilirubinemia (N = 23,711), excluding all cases of hemolytic (immune-mediated or other specified hemolytic) diseases of the newborn. RESULTS: Risk factors with an adjusted odds ratio (aOR) for neonatal hyperbilirubinemia of ≥1.5 (medium-sized effect or more) were gestational age 37 to 38 weeks (aOR = 2.83), failed vacuum extraction (aOR = 2.79), vacuum extraction (aOR = 2.22), Asian mother (aOR = 2.09), primipara (aOR = 2.06), large-for-gestational-age infant (aOR = 1.84), obese mother (aOR = 1.83), and small-for-gestational-age infant (aOR = 1.66). Planned cesarean delivery (CD) was associated with a reduced risk (aOR = 0.45). Without any of these risk factors (normal birth weight infant delivered vaginally at 39 to 41 weeks' gestation by a non-Asian, nonobese, multiparous mother) the rate of nonhemolytic neonatal hyperbilirubinemia was 0.7%. In relation to the combined load of different risk factors, rates of neonatal hyperbilirubinemia ranged from 0.2% to 25%. CONCLUSIONS: Collection of a few easily available maternal and obstetric risk factors predicts >100-fold variation in the incidence of neonatal hyperbilirubinemia. The information provided herein enables individualized risk prediction with interactions between different risk factors taken into account.
Authors: Erica T Wang; Lauren W Sundheimer; Carla Spades; Cara Quant; Charles F Simmons; Margareta D Pisarska Journal: J Pediatr Date: 2017-05-31 Impact factor: 4.406
Authors: L Thielemans; M Trip-Hoving; J Landier; C Turner; T J Prins; E M N Wouda; B Hanboonkunupakarn; C Po; C Beau; M Mu; T Hannay; F Nosten; B Van Overmeire; R McGready; V I Carrara Journal: BMC Pediatr Date: 2018-06-12 Impact factor: 2.125
Authors: Molly E McCarthy; Scott P Oltman; Rebecca J Baer; Kelli K Ryckman; Elizabeth E Rogers; Martina A Steurer-Muller; John S Witte; Laura L Jelliffe-Pawlowski Journal: Clin Transl Sci Date: 2018-10-28 Impact factor: 4.689
Authors: Dewi A Wisnumurti; Yunia Sribudiani; Robert M Porsch; Ani M Maskoen; Sri E Rahayuningsih; Eni K Asni; Frank Sleutels; Wilfred F J van Ijcken; Abdurachman Sukadi; Tri H Achmad Journal: BMC Pediatr Date: 2019-12-20 Impact factor: 2.125